TIMP3 and cancer: The analysis revealed a significant decrease in TIMP3 protein expression in CRC samples compared to normal samples (p ≤ 0.001), as illustrated in Figure 2A. Subsequent subgroup analyses based on cancer stages, gender, and histological subtypes consistently showed lower TIMP3 protein levels in CRC tissues relative to normal tissues (Figure 2B–D).